“…The materials themselves offer some neuroprotection by providing structural support, attenuating gliosis and inflammation, and reducing cavitation. Bioactive materials, like HA, reduce inflammation through the CD44 receptor by inhibiting leukocyte migration and inflammation (Forrester and Wilkinson, 1981;Cooper et al, 2008), resulting in reduced microglial activation (Wang et al, 2012b) and stroke infarct volume (Hou et al, 2005;Austin et al, 2012;Wang et al, 2013;Tuladhar et al, 2015).…”